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Summary A new human rhabdomyosarcoma cell line (HX170c) has been established from a paratesticular
embryonal tumour in a 5-year-old male. The cells grew as an adherent monolayer with a doubling time of
32h and showed pleomorphic features. Intermediate filament analysis revealed the line to be mesenchymal in
origin (reactivity to vimentin and desmin antibodies). The line was tumorigenic in nude mice, possessed
elevated levels of creatine phosphokinase (mainly of the MM isoenzyme form) and had a near diploid mean
chromosome number of 50. In vitro cell cloning determinations gave colony forming efficiencies of 0.01 % in
soft agar and 24% in a monolayer anchorage-dependent assay. Radiosensitivity determinations using a
monolayer clonogenic assay with feeder layer support showed the cells to be among the more radiosensitive
human tumour cell types (surviving fraction at 2Gy of 0.26) that have been investigated. Furthermore,
experiments utilising continuous low dose rate radiation at 3.2cGy min- 1, showed that, under these
experimental conditions, the cells possessed only a very low capacity to recover from radiation-induced
damage (dose reduction factor at 1% cell survival of 1.07 for 150 versus 3.2cGy min-'). As other human
tumour cells of an embryonal cell origin (e.g. neuroblastoma and germ cell tumours of the testis) have also
been shown to be radiosensitive it appears that sensitivity to radiation may be a common property of this
group of tumours.
Rhabdomyosarcoma (RMS) is the most common soft tissue
sarcoma in childhood and represents 8% of all malignant
disease in children under 15 years (Young & Miller, 1975).
The disease may be subdivided into embryonal (which
accounts for about 60%), pleomorphic and alveolar types
(Enzinger & Weiss, 1983). Embryonal RMS is most com-
monly found in head and neck, genitourinary and retroperi-
toneal sites. Progress in the treatment of RMS has been
achieved using combinations of surgery, radiotherapy and
chemotherapy regimes (notably using vincristine, actino-
mycin D and cyclophosphamide, e.g. Quesada et al. (1986).
In recent years a few in vitro RMS cell lines have been
established from both alveolar (Nanni et al., 1986; Garvin et
al., 1986) and embryonal (McAllister et al., 1969; Giard et
al., 1973; Chapman et al., 1974; Clayton et al., 1986) types.
The majority of studies to date with these lines have
concentrated upon cell biological aspects of the disease, such
as tumour specific markers (Nanni et al., 1986; Clayton et
al., 1986), growth factors (Iwata et al., 1985) and in vitro
differentiation properties (Garvin et al., 1986). Few studies
have investigated chemotherapeutic aspects and none to our
knowledge has investigated the radiobiological properties of
this common childhood tumour where radiotherapy plays a
role in its treatment.
Since it has become clear in recent years that the initial
portion of the in vitro radiation cell survival curve for
human tumour cells shows a positive correlation with clinical
radioresponsiveness (Fertil & Malaise, 1981; Deacon et al.,
1984; Steel, 1988), it is of interest to determine radiosensi-
tivity in various human tumour cell types. It has been shown
that other childhood tumours derived from embryonic cell
types, such as neuroblastoma (Deacon et al., 1985; Kelland
et al., 1988), are particularly radiosensitive, possessing steep
initial slopes to their survival curves. In addition, another
embryonal cell type, a germ cell tumour of the testis cell line,
has been shown to be among the more radiosensitive lines
investigated in a series of studies involving human tumour
cells (Kelland et al., 1987a,b; Steel et al., 1987).
In this study we describe the establishment and charac-
terisation of a new RMS cell line designated HX170c. In
addition, by means of a clonogenic cell survival assay,
radiosensitivity has been determined both at a high dose rate
(150cGy min 1) and at a continuous low dose rate of
3.2cGy min 1 As has been shown previously (Mitchell et
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al., 1979a, b; Steel et al., 1986), irradiation of cells of human
origin, which generally have cell cycle times in excess of 24h,
at dose rates of around 3cGymin- allows extensive re-
covery of radiation damage by repair processes without cell
repopulation or cell cycle reassortment occurring, and
enables a more precise indication of the initial slope of the
cell survival curve to be obtained.
Materials and methods
Establishment of cell line
The cell line was established from a biopsy of a para-
testicular embryonal rhabdomyosarcoma (diagnosed to be a
rhabdomyosarcoma by positivity for desmin intermediate
filaments) at the Royal Marsden Hospital in a 5-year-old
caucasian male. The tumour had previously been treated
with radio- and chemotherapy (vincristine, adriamycin and
cyclophosphamide) over a 2-year period but had recurred
locally at the time of biopsy removal in November 1986. The
patient died 2 months after the biopsy was taken.
The biopsy was held in ice-cold Ham's F12 medium con-
taining penicillin (105 unitsP1), streptomycin (100mgI1)
and neomycin (10mg -1) for 2h. The specimen was then
finely chopped with crossed scalpels and rinsed in phosphate
buffered saline (PBS). One-half of the material of 2mm2 size
was implanted subcutaneously into five female (nu/nu) nude
mice to establish xenografts. The remaining half was dis-
aggregated overnight at 37C in Ham's F12 medium contain-
ing 15% fetal calf serum (Imperial Laboratories) and
1 mgml-1 collagenase (Boehringer-Mannheim). After centri-
fugation (lOOg for 5min), single cells and cell aggregates
were seeded into parallel 25cm2 tissue culture flasks (Nunc
products).
The cell line grew as an adherent monolayer culture in
growth medium consisting of Dulbecco's Modified Eagle's
Medium (DMEM) supplemented with 15% fetal calf serum
and containing 105 units 1-1 of penicillin, 100mg1-1 strepto-
mycin, 2mM glutamine in a 5% CO2, 5% 02, 90% N2
atmosphere. In addition, the cells were cultured at early in
vitro passages (up to passage 10) with a lethally irradiated
(200Gy of y-rays from a 60Co source) feeder layer of the
Swiss mouse embryonic fibroblast 3T3 line added at 2 x 105
cells per 25cm2 flask. Growth medium was replaced and
flasks were regassed three times per week. Mycoplasma
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screening was performed routinely by staining with Hoechst
33528 dye and examining under a fluorescent microscope.
Population doubling time determination
Growth curves were constructed by seeding cells at low
density (5 x 104 per 25cm2 flask) and feeding every 48 h.
Cells in triplicate flasks were then detached at 24h intervals
and viable cells counted using lissamine green dye exclusion.
Immunocytochemistry
A standard double-antibody technique using cells fixed on
slides with acetone/methanol was used to detect intermediate
filament proteins by immunofluorescence. Low molecular
weight cytokeratins were detected using CAM 5.2 (Makin et
al., 1984), neurofilaments, vimentin, desmin and desmoplakin
antibodies were obtained from Eurodiagnostics. Rabbit anti-
mouse immunoglobulin conjugated with fluorescein and used
as the second layer antibody was obtained from Zymed and
Miles Inc. In addition, a monoclonal antibody (GCTM-1)
raised in our Department from human embryonal carcinoma
cells, which stains the nuclei of all human cells (Pera et al.,
1988) was used as a positive control for the presence of
human cells. The presence of myoglobin was detected using
a polyclonal antibody obtained from Dako Products Ltd.
Tumorigenicity of cultured cells in nude mice
Female nude (nu/nu) mice housed in plastic film isolator
units were given s.c. injections of 3 x 106 cells suspended in
0.2ml culture medium bilaterally in the flank region.
Tumorigenicity was tested in the 6th and 40th passages of
growth using five mice in each case. Resulting tumours were
then removed, sectioned in paraffin, and stained with Hae-
matoxylin and Eosin.
Cytogenetic analysis
Exponentially growing cells were treated with colcemid
(0.2 igml-1) for 4h and with ethidium bromide (10,ugml-1)
for the final 2h. Cells were then disaggregated (0.02%
EDTA/0.05% trypsin), centrifuged (lOOg, 5min) and swollen
in hypotonic solution (0.075M KCI) at 37°C for Omin. Cells
were then fixed with ice-cold glacial acetic acid: methanol
(1:3), dropped on to ice-cold slides, air dried and stained
with 5% Giemsa for 10min. The mean chromosome number
was determined by counting at least 30 metaphase spreads.
Analysis was at passage 30.
Creatine phosphokinase (CPK) enzyme activity
Both total CPK activity and isoenzyme separation were
determined using kits (Sigma Chemical Co.). Cells were
grown to confluency, washed in PBS and then harvested.
After centrifugation (lOOg, 5min), the resulting cell pellet
was resuspended in 0.5ml PBS and cells were disrupted by
sonication. Total CPK activity determinations utilised
phosphocreatine and ADP as substrates in a colorimetric
analysis. For isoenzyme separation into BB, MB and MM
forms the supernatant was placed on 0.8% agarose gel and,
after electrophoresis, quantitation was achieved using
tetranitro-blue tetrazolium reduction colorimetry.
Colony forming efficiency (CFE)
CFE was determined both in monolayer on plastic and in
soft agar. For both assays, single cell suspensions were
obtained by disaggregation using 0.02% EDTA in 0.05%
trypsin and filtration through a 20gtm polyester mesh.
Assays were then performed as previously described for
other human tumour cell types (Kelland et al., 1987a;
Kelland & Steel, 1988 for monolayer assay; Courtenay &
Mills, 1978; Kelland & Steel, 1986 for soft agar assay).
Briefly, cells (250 to 1 x 104) were seeded and incubated in
'growth medium' as above except that a lethally irradiated
feeder layer of 3T3 cells was included. For the monolayer
assay 2 x 105 feeder cells were added per 60mm plate,
whereas in the soft agar assay 1 x 104 cells per tube were
added. As with a number of other human tumour cell types
studied (Kelland et al., 1987a,b, 1988) no measurable cloning
efficiency was observed in the absence of feeder cells. Cells
were then incubated in a 5% CO2, 5% 02, 90% N2
atmosphere for 15 days for the monolayer assay and 21 days
for the soft agar assay. Monolayer cultures were washed and
stained using 0.5% methylene blue; soft agar cultures were
decanted on to slides. In both cases, colonies greater than 50
cells were scored.
Irradiation procedure
Single cells were plated out according to the monolayer
clonogenic assay described above and radiation survival
using 60Co y-rays determined as previously described for
other human tumour cell types (Kelland et al., 1987a, b,
1988). Briefly, cells were gassed for 30min with a 90% N2,
5% CO2, 5% 02 mixture, sealed into boxes, incubated at
37°C for 90min and then irradiated. High (150cGymin-1)
and low (3.2cGymin-1) irradiations were performed using
either a 2,000Ci or a 10OCi source, both with identical
geometry. Irradiations were carried out with cells at 37°C.
Cells were then incubated for 14 days and colonies contain-
ing greater than 50 cells counted.
Statistical analysis
Radiation survival points represent the mean+standard error
of at least three experiments. Single survival curves were
fitted using the incomplete repair model for survival under
continuous irradiation (Thames, 1985).
Results
The cell line HX170c has now been growing in tissue culture
for 15 months and has been passaged at least 80 times.
Figure 1 shows the phase contrast morphological properties
of the cells. The line showed pleomorphic morphological
features with considerable variation in the size and shape of
cells. Small mononucleated polygonal cells, spindle-shaped,
stellate and rounded cells were present. In addition, at higher
density, when cells were near confluent, a few multinucleated
elongated cells resembling myotube structures were observed.
No such structures were observed in freshly seeded cultures.
All of the above morphological phenotypes appeared to be
stable with continued passaging. The in vitro doubling time
of the cells was 32 h; cells were found to be free of
mycoplasma contamination. Cytogenetic analysis from 30
metaphase spreads at passage 30 of growth revealed a near
diploid mean chromosome number of 50 +6 (s.d.).
Figure 1 Colony morphology of HX170c. Cells are in their
twentieth passage of growth. Phase contrast microscopy, x 160.162 L.R. KELLAND et al.
Immunocytochemistry
In order to better define the in vitro properties of HXl70c
cells, the expression of various intermediate filaments and
myoglobin has been determined. All cells were strongly
positive for the expression of vimentin type filaments (a
marker for cells of mesenchymal origin) but were negative
for neurofilaments, desmoplakins and cytokeratins. All cells
were negative for the presence of myoglobin and almost all
cells were negative for desmin expression. However, when
cells were grown to near confluency, the occasional large
multinucleated elongated cells were positive for desmin
expression. In addition, when cells were injected s.c. into
nude mice, the resulting tumour sections possessed numerous
areas positive for desmin expression. All cells were positive
against the GCTM-I monoclonal antibody found to be
specific for human cells.
Tumorigenicity
When 170c cells were injected into nude mice at passage 6 or
40, they resulted in the formation of tumours after 5-6
weeks. The cells were highly tumorigenic, with all injection
sites giving rise to tumours. The xenograft tumours were
serially transplantable in further mice as a stable line and
appeared to be well vascularised, containing few necrotic
areas. In addition, a stable serially transplantable xenograft
line was established by implantation of original tumour
biopsy material. A histological comparison of the tumours
formed in nude mice with the original patient biopsy is
shown in Figure 2 (a is original biopsy; b is xenograft from
original biopsy; and c is xenograft from cell line). Figure 2a
shows the original biopsy to contain large areas of small
undifferentiated tumour cells. The xenograft lines again show
areas of undifferentiated small tumour cells with numerous
mitoses.
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Figure 2 Histology sections of (a) tumour biopsy taken from
patient at the time when resulting cell line was initiated, (b)
tumour arising in nude mice from implantation of biopsy
material and (c) tumour arising in nude mice from s.c. injection
of 3 x 106 cells of HX170c. Cell line was in its fortieth passage of
growth at the time of injection. H and E, x 250.
CPK analysis
HX170c cells showed elevated levels of total CPK activity,
levels being three-fold higher per cell than in the mouse 3T3
fibroblast line. In normal myogenesis transition from the BB
homodimer (fetal form) through the MB heterodimer to the
MM (adult) form of enzyme occurs. Isoenzyme separation
using 0.8% agarose gels showed the HX170c cells to contain
mostly the MM form (approximately 60% by eye), virtually
no MB form and about 35% BB form.
Colony forming efficiency and radiosensitivity
CFE values for cloning in soft agar were less than 0.01%,
whereas in the monolayer cloning assay a value of 24+4(s.e.)








0 2 4 6 8
Radiation dose (Gy)
10 12
Figure 3 Cell survival of HX170c cells irradiated with 60Co y-
rays at high dose-rate (150cGymin-m) (0) and at a continuous
low dose-rate of 3.2cGymin-1 (A). Full lines are calculated by
fitting to the incomplete repair model (Thames, 1985).
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Table I Summary of radiation survival and recovery parameters
Dose-rate (cGymin-1) (±s.e.)
Dose-rate dependence 150 3.2
Multitarget model
Do (Gy) 1.27 +0.03 1.34 +0.05
n 1.49 +0.14 1.74 +0.23
Linear quadratic model
a (Gy-1) 0.64 +0.002 0.503+0.003
fi (Gy -2) 0.014+0.001 0.025+0.001
SF a 0.26 0.33
DRFb 1.07
aSurviving fraction at 2Gy.
bDRF=dose reduction factor (ratio of isoeffect 1% cell survival)
doses at 150 versus 3.2cGy min- dose-rates).
(determined using the monolayer cloning assay) for HX170c
at both high and low radiation dose-rate. At the high dose-
rate of 150cGy min -1 the curve is almost exponential in
shape, possessing a negligible initial shoulder at low doses.
Irradiation at the low dose rate of 3.2cGy min- 1, which
allows repair processes to operate during irradiation, results
in a very small shift in the curve to the right. Cell survival
parameters derived from these curves are shown in Table I.
Discussion
To date, relatively few cell lines have been established from
this important tumour of childhood (McAllister et al., 1969;
Giard et al., 1973; Clayton et al., 1986), possibly reflecting a
difficulty in establishing these cell types in vitro. In addition,
some alveolar RMS lines have been established (Nanni et al.,
1986; Garvin et al., 1986). The biological properties of the
HX170c cell line described here are consistent with it being
derived from a human embryonal rhabdomyosarcoma and it
shows a number of similar features to the existing cell lines.
The cell line was confirmed as human in origin by
reactivity against the GCTM-1 monoclonal antibody and to
be tumorigenic in nude mice. Where tumorigenicity has been
investigated in existing lines (Giard et al., 1973; Nanni et al.,
1986; Garvin et al., 1986; Clayton et al., 1986) tumours have
also arisen after about the same time of 6 weeks. Indeed the
lines described by Hazelton et al. (1987) were established
from xenograft lines. Cytogenetic analysis showed a near
diploid mean chromosome number of 50, a number close to
that observed in some other lines (Giard et al., 1973;
Chapman et al., 1974; McAllister et al., 1969; Garvin et al.,
1986). However, occasionally much higher chromosome
numbers of around 85 per cell have been observed (Clayton
et al., 1986; Nanni et al., 1986).
The development of intermediate filament analysis has
aided the classification of human tumours (Osborn & Weber,
1982). The diagnosis of RMS has been helped by the finding
that, in biopsy sections, RMS and leiomyosarcoma are
reactive with desmin-type intermediate filaments (Osborn et
al., 1984; Altmannsberger et al., 1985). Although cell lines
derived from RMS have also been shown to react with anti-
desmin monoclonal antibodies, the proportion of positive-
staining cells has varied from around 80-90% in the human
RD line (Debus et al., 1983) and 80% in the RMZ alveolar
RMS line (Nanni et al., 1986) to around 20-30% in the JR1
embryonal RMS line (Clayton et al., 1986). We observed
desmin expression in only around 5% of cells when seeded
at low density, in around 20% of the population (particu-
larly in elongated multinucleated cells) when cells were near
confluent and in about 60% of tumour areas in xenograft
sections derived from the cells (a similar proportion to the
original biopsy). These findings emphasise the importance of
cell growth conditions for desmin expression.
As with other cell lines (Clayton et al., 1986; Hazelton et
al., 1987), the HX170c cells were positive for vimentin
expression, thus confirming the mesenchymal origin of the
cells. In addition, in agreement with previous findings, the
cells were negative for cytokeratin expression. Myoglobin
has also been proposed as a marker for RMS (Corson &
Pinkus, 1981), although it is now apparent that not all are
identified (Altmannsberger et al., 1985). We did not detect
myoglobin in either the cells or resulting xenograft lines.
Other RMS cell lines have also been shown to be negative
for myoglobin expression (McAllister et al., 1969; Clayton et
al., 1986).
Creatine phosphokinase (CPK) isoenzyme determinations
are also useful in characterizing RMS. We have shown
HX170c to possess elevated CPK levels largely of the 'adult'
MM homodimer. Where isoenzyme levels have been mea-
sured in other RMS lines the MM form is usually dominant
(Hazelton et al., 1987). As the MM form is dominant in all
stages of skeletal muscle development our findings are not
surprising. However, Garvin et al. (1986) have reported the
BB form to be dominant in a RMS cell line.
Colony forming efficiency determinations revealed large
differences in cloning ability in soft agar (0.01%) compared
to an anchorage-dependent monolayer assay (24%). Interest-
ingly, in the only other investigation we know of where cell
cloning has been attempted in a human RMS cell line (Giard
et al., 1973 for the A-673 line) a similar result was obtained
(cloning efficiencies of 2.4% in agar and 70% in monolayer).
In addition, we have seen this difference in cloning ability
between soft agar and monolayer assays for other human
tumour cell types, particularly lines of epithelial origin (e.g.
carcinoma of the cervix; Kelland et al., 1987a).
As far as we are aware this is the first time a human
rhabdomyosarcoma cell line has been the subject of a
radiobiological analysis. On comparison with over 20 other
human tumour cell types that we have looked at in our
laboratory (Steel et al., 1987; Steel, 1988 for reviews) the
HX170c RMS cell line with a Do of 1.27Gy, oc of 0.64Gy
and a SF2 value of 0.26 is among the most radiosensitive.
The SF2 value for human tumour cells has been shown to be
a good discriminator between clinically radioresponsive and
unresponsive tumour types (Deacon et al., 1984). According
to this classification of radiosensitivity HX170c may be
assigned to Group B, the group containing medulloblastoma,
small cell lung carcinoma and teratoma. As well as being
quite radiosensitive, survival measured at the low dose rate
of 3.2cGymin-1 indicates that the cells, under these experi-
mental conditions, appear to possess only a small capacity to
recover from radiation damage (Figure 3, DRF of only 1.07
from Table I). This DRF value is one of the lowest we have
observed among the human tumour cell lines studied (where
we have found DRF values ranging from 1.0 to 2.1 (Steel et
al. 1987).
In addition to the observed correlation between SF2 and
clinical radioresponsiveness (Deacon et al., 1984; Steel,
1988), it has been proposed that the degree of potentially
lethal damage repair (PLDR) (that observed by delayed
plating experiments) observed in vitro in human tumour cells
may also correlate with clinical responsiveness
(Weichselbaum & Beckett, 1987; Weichselbaum et al., 1982).
Therefore it would appear that PLDR experiments may
represent an alternative strategy for examining radiosensi-
tivity and correlations with radioresponsiveness. However, in
view of the difficulty in obtaining true plateau phase cells
with human tumour cells which are not contact inhibited as
confluent monolayers, combined with recent evidence that
has not shown any such correlation (Marchese et al., 1987),
we believe that the SF2 and low dose rate determinations
described above provide the ideal means of assessing radio-
sensitivity in vitro.
Obviously from data representing only one cell line it is
not possible to predict whether the radiosensitive properties
of HX170c found here are a general characteristic of human
RMS. However, of interest is the finding that other human
cell lines of an embryonal cell origin are also radiosensitive.
For example, neuroblastoma cell lines have been shown to164 L.R. KELLAND et al.
be even more radiosensitive (Deacon et al., 1985; Kelland
et al., 1988). In addition we have shown a germ cell tumour
of the testis cell line to be of about the same radiosensitivity
(Kelland et al., 1987b). At present it is not clear why tumour
cells of an embryonal cell origin generally appear to be
intrinsically more radiosensitive than the majority of human
tumour cell types. It is possible that these cells are deficient
in some DNA-repair pathway or that they incur more initial
damage per radiation dose due to differences in chromatin
organisation. As yet no such differences have been observed.
Further studies on additional cell lines of embryonal origin
(which have thus far proved difficult to establish) are
necessary. These questions are important to answer in order
to elucidate what makes a cell sensitive to radiation and
whether such determinants may be manipulated in more
radioresistant tumours. The HX170c cell line described in
this study may prove useful for investigating some of these
questions.
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